Munir A Hussain

Title: Munir A Hussain: Innovator in Pharmaceutical Dosage Forms

Introduction

Munir A Hussain is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel dosage forms. With a total of 3 patents to his name, his work has had a meaningful impact on medication delivery systems.

Latest Patents

Hussain's latest patents include a groundbreaking pharmaceutical product that combines efavirenz, emtricitabine, and tenofovir DF into a multicomponent unitary oral dosage form. This innovative formulation features two components: component 1, which includes tenofovir DF (and optionally emtricitabine), and component 2, which comprises efavirenz. The components are designed to be in a stabilizing configuration, enhancing the efficacy of the medication. In preferred embodiments, component 1 is produced through dry granulation, showcasing Hussain's commitment to improving pharmaceutical formulations.

Career Highlights

Munir A Hussain has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb and Gilead Sciences, Inc. His expertise in pharmaceutical sciences has allowed him to contribute to the development of innovative products that address critical health needs.

Collaborations

Throughout his career, Hussain has collaborated with esteemed colleagues such as Terrence C Dahl and Robert A Lipper. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of pharmaceutical technologies.

Conclusion

Munir A Hussain's contributions to the field of pharmaceuticals, particularly through his innovative dosage forms, highlight his role as a key inventor in the industry. His work continues to influence the development of effective medication delivery systems.